Research Progress on Sesquiterpenoids of Curcumae Rhizoma and Their Pharmacological Effects
- PMID: 38672405
- PMCID: PMC11048675
- DOI: 10.3390/biom14040387
Research Progress on Sesquiterpenoids of Curcumae Rhizoma and Their Pharmacological Effects
Abstract
Curcumae Rhizoma, a traditional Chinese medicine with a wide range of pharmacological activities, is obtained from the dried rhizomes of Curcuma phaeocaulis VaL., Curcuma kwangsiensis S. G. Lee et C. F. Liang, and Curcuma wenyujin Y. H. Chen et C. Ling. Sesquiterpenoids and curcuminoids are found to be the main constituents of Curcumae Rhizoma. Sesquiterpenoids are composed of three isoprene units and are susceptible to complex transformations, such as cyclization, rearrangement, and oxidation. They are the most structurally diverse class of plant-based natural products with a wide range of biological activities and are widely found in nature. In recent years, scholars have conducted abundant studies on the structures and pharmacological properties of components of Curcumae Rhizoma. This article elucidates the chemical structures, medicinal properties, and biological properties of the sesquiterpenoids (a total of 274 compounds) isolated from Curcumae Rhizoma. We summarized extraction and isolation methods for sesquiterpenoids, established a chemical component library of sesquiterpenoids in Curcumae Rhizoma, and analyzed structural variances among sesquiterpenoids sourced from Curcumae Rhizoma of diverse botanical origins. Furthermore, our investigation reveals a diverse array of sesquiterpenoid types, encompassing guaiane-type, germacrane-type, eudesmane-type, elemane-type, cadinane-type, carane-type, bisabolane-type, humulane-type, and other types, emphasizing the relationship between structural diversity and activity. We hope to provide a valuable reference for further research and exploitation and pave the way for the development of new drugs derived from medicinal plants.
Keywords: Curcumae Rhizoma; chemical constituents; pharmacological activity; sesquiterpenoids.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures








Similar articles
-
Establishment of an antiplatelet aggregation efficacy-oriented effect-constituent index for quality evaluation of Curcumae Rhizoma from different species (Curcuma phaeocaulis Val, Curcuma kwangsiensis S. G. Lee et C. F. Liang and Curcuma wenyujin Y. H. Chen et C. Ling).Fitoterapia. 2024 Oct;178:106169. doi: 10.1016/j.fitote.2024.106169. Epub 2024 Aug 3. Fitoterapia. 2024. PMID: 39102903
-
Molecular genetic and chemical assessment of Rhizoma Curcumae in China.J Agric Food Chem. 2005 Jul 27;53(15):6019-26. doi: 10.1021/jf0508495. J Agric Food Chem. 2005. PMID: 16028990
-
[Study on quality identification of Curcumae Rhizoma from different origins based on quantitative analysis of appearance color and content of main components].Zhongguo Zhong Yao Za Zhi. 2021 Mar;46(6):1393-1400. doi: 10.19540/j.cnki.cjcmm.20201111.301. Zhongguo Zhong Yao Za Zhi. 2021. PMID: 33787137 Chinese.
-
Curcumae Rhizoma: An anti-cancer traditional Chinese medicine.Chin Herb Med. 2025 Apr 24;17(3):428-447. doi: 10.1016/j.chmed.2025.04.006. eCollection 2025 Jul. Chin Herb Med. 2025. PMID: 40734908 Free PMC article. Review.
-
Potential roles and molecular mechanisms of bioactive ingredients in Curcumae Rhizoma against breast cancer.Phytomedicine. 2023 Jun;114:154810. doi: 10.1016/j.phymed.2023.154810. Epub 2023 Apr 6. Phytomedicine. 2023. PMID: 37075623 Review.
Cited by
-
Curzerenone inactivates the nuclear factor-kappa B signaling to suppress malignancy and immune evasion in cervical cancer by targeting CSNK2B.Hum Cell. 2024 Dec 24;38(1):35. doi: 10.1007/s13577-024-01164-w. Hum Cell. 2024. PMID: 39718697
References
-
- Liu Y., Ma J.H., Wang Y., Donkor P.O., Li Q., Gao S.Y., Hou Y.G., Xu Y., Cui J.N., Ding L.Q., et al. Eudesmane-Type Sesquiterpenes from Curcuma phaeocaulis and Their Inhibitory Activities on Nitric Oxide Production in RAW 264.7 Cells. Eur. J. Org. Chem. 2014;2014:5540–5548. doi: 10.1002/ejoc.201402465. - DOI
-
- National PC . Pharmacopoeia of the People’s Republic of China (I) Chinese Medical Science and Technology Press; Beijing, China: 2020. pp. 286–287.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources